Trade Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - 0874 CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.15
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.01846 %(-HK$3.69)Trade size with leverage ~ HK$20,000.00Money from leverage ~ $HK$19,000.00Go to platform: -0.01846%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.00346 %(-HK$0.69)Trade size with leverage ~ HK$20,000.00Money from leverage ~ $HK$19,000.00Go to platform: -0.00346%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: HKD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: Hong Kong
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.01846 %
  (-HK$3.69)

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00346 %
  (-HK$0.69)

Key Stats

• Prev. Close: 13.25
• Open: 13.3
• 1-Year Change: -26.32%
• Day's Range: 13.2 - 13.45

Trade Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - 0874

About Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd revenues increased 12% to RMB69.01B. Net income increased 28% to RMB3.72B. Revenues reflect Business segment increase of 8% to RMB46.89B, Health segment increase of 38% to RMB10.87B, Foreign segment increase of 7% to RMB42.8M. Net income benefited from Change in Fair value decrease from RMB8.5M (expense) to RMB196.9M (income).